Nucleoside reverse transcriptase inhibitors (NRTIs)

5 14 Pill - yellow capsule-shape, 19mm

Pill with imprint 5 14 is Yellow, Capsule-shape and has been identified as Abacavir Sulfate 300 mg. It is supplied by Cipla USA Inc.

Abacavir is used in the treatment of HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Abacavir (Abacavir [ a-bak-a-veer ])-5 14-300 mg-Yellow-Capsule-shape
Abacavir (Abacavir [ a-bak-a-veer ])-5 14-300 mg-Yellow-Capsule-shape

Abacavir
Generic Name: abacavir [ a-bak-a-veer ]
Imprint: 5 14
Strength: 300 mg
Color: Yellow
Size: 19.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 69097-0514
Inactive Ingredients: Microcrystalline cellulose, Corn starch, Magnesium stearate, Silicon dioxide, Titanium dioxide, Hypromellose 2910 (3 mPa.s), Polyethylene glycol 400, Ferric oxide yellow, Polysorbate 80,
Latest News
Related Drugs